Sera Prognostics, Inc.
2749 East Parleys Way
Suite 200
Salt Lake City, UT 84109
United States
801 990 0520
https://seraprognostics.com
版塊: Healthcare
行業: Diagnostics & Research
全職員工: 55
高階主管
| 名稱 | 頭銜 | 支付 | 行使價 | 出生年份 |
|---|---|---|---|---|
| Ms. Evguenia Lindgardt M.B.A. | President, CEO & Director | 622.42k | 無 | 1974 |
| Mr. Austin Aerts | Chief Financial Officer?? | 367.62k | 無 | 1987 |
| Dr. John J. Boniface Ph.D. | Chief Scientific Officer | 467.32k | 無 | 1962 |
| Dr. Gregory C. Critchfield M.D., M.S. | Executive Director | 1.04M | 無 | 1953 |
| Dr. Steven W. Graves | Co-Founder and Co-Chairman of The Scientific Advisory Board | 無 | 無 | 無 |
| Dr. M. Sean Esplin M.D. | Co-Founder and Co-Chairman of Scientific Advisory Board | 無 | 無 | 無 |
| Mr. Robert G. Harrison | Chief Information Officer | 384.18k | 無 | 1966 |
| Mr. Benjamin G. Jackson J.D. | General Counsel | 410.75k | 無 | 1979 |
| Dr. Paul Kearney Ph.D. | Chief Data Officer | 無 | 無 | 1968 |
描述
Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes in the United States. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preterm birth, preeclampsia, molecular time-to-birth, predictive analytics, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
公司管治
截至 無 止，Sera Prognostics, Inc. 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。
